Apply for a Research Grant

FUNDING FOR HIGH-IMPACT PEDIATRIC CANCER RESEARCH

Solving Kids' Cancer is a nonprofit organization with a track-record of funding novel clinical research for children diagnosed with high-risk solid tumors specifically neuroblastoma, brain tumors and sarcomas.

The Therapeutic Development Initiative (TDI) is SKC's strategic platform for the implementation of our research agenda. The TDI's goal is to support innovative early phase clinical studies that are high on the risk/reward spectrum. Priority is given to proposals that introduce novel therapeutic agents and modalities and have a strong potential to improve treatment outcomes.

KEY POINTS

  •    The TDI of SKC only supports clinical research, with focus on novel clinical studies for neuroblastoma, brain tumors and sarcomas.
  •    Proposals are accepted and reviewed throughout the year on a rolling basis.
  •    Funding award amounts generally range from $50,000 to $600,000

SUBMITTING A CLINICAL IDEA OF INTENT TO THE TDI - GUIDELINES

  •    Novel investigational agents, combinations, administrations, sequences with strong rationale
  •    Study protocol to be submitted for IRB approval within 6-months of award
  •    Study designed to answer hypothesis quickly:

         ◦    Phase Ø, Proof-of-Concept, Pilot Study or small Phase I study design          

         ◦    Enrollment to be completed within two years of IRB approval

  •    Study will include initial assessment of efficacy of promising therapy
  •    Correlative component is encouraged
  •    No institutional overhead or indirect funding will be provided under the terms of the grant

PROPOSAL LOGISTICS

Proposal Format

The Clinical Idea of Intent (brief proposal) in PDF format may be submitted by emailing grants@solvingkidscancer.org

Review

The review period is 3 - 6 weeks. If the initial review is favorable, the TDI will request a more detailed proposal or seek further discussions to identify potential funding collaboration. Requesting additional proposal information after triage review of a Clinical Idea of Intent does not guarantee approval.

Approval

Approval of all TDI Proposals are made by the TDI Scientific Advisory Board and the Solving Kids’ Cancer Board of Directors. After approval, a Project Grant Agreement will be written and agreed upon by the Investigator/Institution and the Charity.

Award Amounts

TDI Awards are funded in a range from $50,000 to $600,000 depending on the nature of the proposed project. No institutional overhead or indirect funding will be provided.

ADDITIONAL INFORMATION

Eligibility

  • SKC welcomes applications from researchers within or outside the United States.
  • Companies interested in support for clinical efforts in pediatrics are welcome to apply.

Applicable to all Submitted Proposals

  • Application and required documents must be in English
  • No institutional overhead or indirect funding will be provided.
  • All submissions are considered confidential and are available to the Scientific Advisory Board, the Board of Directors, and the staff of SKC only

Qualifications and Conditions

  • All awards will be payable to grant recipients to use for the purposes of the submitted grant only
  • Personnel costs may not exceed 15-20% of the budget. Exceptions may be made for proposals documenting a request for more than 20%.

QUESTIONS

Email us at grants@solvingkidscancer.org. We are happy to answer any questions related to submitting a proposal for funding.

Receive Grant Alerts

To receive quarterly emails from SKC about grant opportunities, please email info@solvingkidscancer.org. Solving Kids' Cancer will not sell, share or trade your personal information with a third party for any reason. Correspondence will strictly be to announce grant opportunities.